Developing a Comprehensive Approach for Managing Cardiorenal Metabolic Diseases (CRMD) in Saudi Arabia: Thinking beyond Single Disease-Literature Review and Multidisciplinary Consensus Report.

Diabetes Ther · 2026 · PMC12909734 · PMID 41317223

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

The PIONEER-6 trial, although smaller and shorter in duration, confirmed the cardiovascular safety of oral semaglutide, showing a favorable trend toward reduced cardiovascular death.

also in 993 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.